Cynthia Doerr is invited to present a lecture entitled "Experience using hiomogeneous Sn-117m colloid for RSO", at the Canadian Association of Nuclear Medicine 2018 Annual Meeting, March 22-25, 2018, Vancouver BC, Canada.
Six presentations related to Sn-117m were presented at the 9th International Conference on Isotopes in Doha, Qatar November 12-16, 2017, including “Simulation of Sn-117m radiosynoviorthesis including phagocytotic migration within the joint” by Nigel Stevenson, “Nuclear medicine applications of the novel theranostic…
Nigel Stevenson is invited to present a lecture entitled "Tin-117m: A new isotope and approach to radiosynoviorthesis and other therapies" at the 39th High Country Nuclear Medicine Conference, March 3-7, 2018, at Sun Valley ID.
Dr Gonzales presented the history and development of Serene, LLC, and its many products and opportunities related to Sn-117m.
Dr Stevenson discussed manufacturing of the homogeneous Sn-117m colloid as well as other Sn-117m-related products.
Dr Doerr presented data related to the pre-clinical trials in rats and dogs related to homogeneous Sn-117m colloid, and human clinical trials that will begin in Canada in 2018.
Today Serene LLC's veterinary subsidiary, Convetra Inc, completed enrollment of a clinical trial involving reinjecting Synovetin-OA in client-owned dog with naturally occurring Grade 1-3 osteoarthritis of the elbow. These subjects will be followed for twelve months, with results reported in…
THE WOODLANDS, Texas. September 26, 2017—MWI Animal Health and Securos Surgical, both a part of AmerisourceBergen, have made an investment in the emerging pipeline of Serene, LLC, and will negotiate a distribution partnership with its veterinary subsidiary, Convetra, Inc. “This…
Six abstracts related to Sn-117m have been accepted for either poster or platform presentation at the 9th International Conference on Isotopes in Doha, Qatar November 12-16, 2017, including “Simulation of Sn-117m radiosynoviorthesis including phagocytotic migration within the joint”, “Nuclear medicine applications…
Today, Serene LLC's veterinary subsidiary, Convetra Inc, completed enrollment of its second clinical trial using Synovetin-OA in client owned dogs with grade 3 osteoarthritis of the elbow. These subjects will be followed for 12 months, with results anticipated in 2018.